Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)

Kai Uwe Lewandrowski; Kenneth Blum; Alexander P.L. Lewandrowski; Panayotis K. Thanos; Albert Pinhasov; Alireza Sharafshah; David Baron; Mark S. Gold; Catherine A. Dennen; Igor Elman; Aballa Bowirrat; Edward J. Modestino; Foojan Zeine; Nicole Jafari; Keerthy Sunder; Milan T. Makale; John Giordano; Marjorie C. Gondre-Lewis; Marco Lindenau; Brian S. Fuehrlein; Rajendra D. Badgaiyan; Chynna Levin; Sergio Luis Schmidt; Rossano Kepler Alvim Fiorelli

doi:10.3389/fpubh.2025.1737084

Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)

Kai Uwe Lewandrowski
, Kenneth Blum
, Alexander P.L. Lewandrowski
, Panayotis K. Thanos
, Albert Pinhasov
, Alireza Sharafshah
, David Baron
, Mark S. Gold
, Catherine A. Dennen
, Igor Elman
, Aballa Bowirrat
, Edward J. Modestino
, Foojan Zeine
, Nicole Jafari
, Keerthy Sunder
, Milan T. Makale
, John Giordano
, Marjorie C. Gondre-Lewis
, Marco Lindenau
, Brian S. Fuehrlein

Rajendra D. Badgaiyan, Chynna Levin, Sergio Luis Schmidt, Rossano Kepler Alvim Fiorelli

Department of Psychiatry & Behavioral Sciences

Producción científica: Comment/debate › revisión exhaustiva

Resumen

Substance Use Disorders and Behavioral Addictions The title of this article was erroneously given as “Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying genetic/epigenetic predisposition to hypodopaminergia.” The correct title of the article is “Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.” The original version of this article has been updated.

Idioma original	English (US)
Número de artículo	1737084
Publicación	Frontiers in Public Health
Volumen	13
DOI	https://doi.org/10.3389/fpubh.2025.1737084
Estado	Published - 2025

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health

Acceder al documento

10.3389/fpubh.2025.1737084

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)'. En conjunto forman una huella única.

Citar esto

Lewandrowski, K. U., Blum, K., Lewandrowski, A. P. L., Thanos, P. K., Pinhasov, A., Sharafshah, A., Baron, D., Gold, M. S., Dennen, C. A., Elman, I., Bowirrat, A., Modestino, E. J., Zeine, F., Jafari, N., Sunder, K., Makale, M. T., Giordano, J., Gondre-Lewis, M. C., Lindenau, M., ... Fiorelli, R. K. A. (2025). Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872). Frontiers in Public Health, 13, Artículo 1737084. https://doi.org/10.3389/fpubh.2025.1737084

Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872). / Lewandrowski, Kai Uwe; Blum, Kenneth; Lewandrowski, Alexander P.L. et al.
En: Frontiers in Public Health, Vol. 13, 1737084, 2025.

Producción científica: Comment/debate › revisión exhaustiva

Lewandrowski, KU, Blum, K, Lewandrowski, APL, Thanos, PK, Pinhasov, A, Sharafshah, A, Baron, D, Gold, MS, Dennen, CA, Elman, I, Bowirrat, A, Modestino, EJ, Zeine, F, Jafari, N, Sunder, K, Makale, MT, Giordano, J, Gondre-Lewis, MC, Lindenau, M, Fuehrlein, BS, Badgaiyan, RD, Levin, C, Schmidt, SL & Fiorelli, RKA 2025, 'Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)', Frontiers in Public Health, vol. 13, 1737084. https://doi.org/10.3389/fpubh.2025.1737084

Lewandrowski KU, Blum K, Lewandrowski APL, Thanos PK, Pinhasov A, Sharafshah A et al. Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872). Frontiers in Public Health. 2025;13:1737084. doi: 10.3389/fpubh.2025.1737084

@article{09b17b90d24e4ddf9887265c95bb29f9,

title = "Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)",

abstract = "Substance Use Disorders and Behavioral Addictions The title of this article was erroneously given as {\textquotedblleft}Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying genetic/epigenetic predisposition to hypodopaminergia.{\textquotedblright} The correct title of the article is {\textquotedblleft}Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.{\textquotedblright} The original version of this article has been updated.",

keywords = "Reward Deficiency Syndrome (RDS), addiction and mood disorders, dopamine D2 receptor (DRD2), genetic predisposition, hypodopaminergia, neurotransmitter regulation, pro-dopaminergic therapy, stress induced anxiety",

author = "Lewandrowski, \{Kai Uwe\} and Kenneth Blum and Lewandrowski, \{Alexander P.L.\} and Thanos, \{Panayotis K.\} and Albert Pinhasov and Alireza Sharafshah and David Baron and Gold, \{Mark S.\} and Dennen, \{Catherine A.\} and Igor Elman and Aballa Bowirrat and Modestino, \{Edward J.\} and Foojan Zeine and Nicole Jafari and Keerthy Sunder and Makale, \{Milan T.\} and John Giordano and Gondre-Lewis, \{Marjorie C.\} and Marco Lindenau and Fuehrlein, \{Brian S.\} and Badgaiyan, \{Rajendra D.\} and Chynna Levin and Schmidt, \{Sergio Luis\} and Fiorelli, \{Rossano Kepler Alvim\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2025 Lewandrowski, Blum, Lewandrowski, Thanos, Pinhasov, Sharafshah, Baron, Gold, Dennen, Elman, Bowirrat, Modestino, Zeine, Jafari, Sunder, Makale, Giordano, Gondre-Lewis, Lindenau, Fuehrlein, Badgaiyan, Levin, Schmidt and Fiorelli.",

year = "2025",

doi = "10.3389/fpubh.2025.1737084",

language = "English (US)",

volume = "13",

journal = "Frontiers in Public Health",

issn = "2296-2565",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Correction

T2 - Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia (Frontiers in Public Health, (2025), 13, (1594872), 10.3389/fpubh.2025.1594872)

AU - Lewandrowski, Kai Uwe

AU - Blum, Kenneth

AU - Lewandrowski, Alexander P.L.

AU - Thanos, Panayotis K.

AU - Pinhasov, Albert

AU - Sharafshah, Alireza

AU - Baron, David

AU - Gold, Mark S.

AU - Dennen, Catherine A.

AU - Elman, Igor

AU - Bowirrat, Aballa

AU - Modestino, Edward J.

AU - Zeine, Foojan

AU - Jafari, Nicole

AU - Sunder, Keerthy

AU - Makale, Milan T.

AU - Giordano, John

AU - Gondre-Lewis, Marjorie C.

AU - Lindenau, Marco

AU - Fuehrlein, Brian S.

AU - Badgaiyan, Rajendra D.

AU - Levin, Chynna

AU - Schmidt, Sergio Luis

AU - Fiorelli, Rossano Kepler Alvim

N1 - Publisher Copyright: Copyright © 2025 Lewandrowski, Blum, Lewandrowski, Thanos, Pinhasov, Sharafshah, Baron, Gold, Dennen, Elman, Bowirrat, Modestino, Zeine, Jafari, Sunder, Makale, Giordano, Gondre-Lewis, Lindenau, Fuehrlein, Badgaiyan, Levin, Schmidt and Fiorelli.

PY - 2025

Y1 - 2025

N2 - Substance Use Disorders and Behavioral Addictions The title of this article was erroneously given as “Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying genetic/epigenetic predisposition to hypodopaminergia.” The correct title of the article is “Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.” The original version of this article has been updated.

AB - Substance Use Disorders and Behavioral Addictions The title of this article was erroneously given as “Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying genetic/epigenetic predisposition to hypodopaminergia.” The correct title of the article is “Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.” The original version of this article has been updated.

KW - Reward Deficiency Syndrome (RDS)

KW - addiction and mood disorders

KW - dopamine D2 receptor (DRD2)

KW - genetic predisposition

KW - hypodopaminergia

KW - neurotransmitter regulation

KW - pro-dopaminergic therapy

KW - stress induced anxiety

UR - https://www.scopus.com/pages/publications/105023592899

UR - https://www.scopus.com/pages/publications/105023592899#tab=citedBy

U2 - 10.3389/fpubh.2025.1737084

DO - 10.3389/fpubh.2025.1737084

M3 - Comment/debate

C2 - 41334398

AN - SCOPUS:105023592899

SN - 2296-2565

VL - 13

JO - Frontiers in Public Health

JF - Frontiers in Public Health

M1 - 1737084

ER -